Regeneron to buy bankrupt genetic testing firm 23andMe for $256M

finance.yahoo.com/news/regeneron-buy-bankrupt-genetic-testing-114337004.html

In This Article:
(Reuters) -Drugmaker Regeneron Pharmaceuticals (REGN) will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, the companies said on Monday.
Regeneron said it will comply with 23andMe's privacy policies and applicable laws with respect…

This story appeared on finance.yahoo.com, 2025-05-19 11:43:37.
The Entire Business World on a Single Page. Free to Use →